- Home
- PVLA vs LNKB Comparison
PVLA vs LNKB Comparison
Compare PVLA & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- LNKB
- Stock Information
- Founded
- PVLA 2015
- LNKB 2018
- Country
- PVLA United States
- LNKB United States
- Employees
- PVLA N/A
- LNKB N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- LNKB
- Sector
- PVLA Health Care
- LNKB
- Exchange
- PVLA Nasdaq
- LNKB Nasdaq
- Market Cap
- PVLA 249.2M
- LNKB 256.4M
- IPO Year
- PVLA N/A
- LNKB N/A
- Fundamental
- Price
- PVLA $25.92
- LNKB $7.49
- Analyst Decision
- PVLA Strong Buy
- LNKB Strong Buy
- Analyst Count
- PVLA 7
- LNKB 1
- Target Price
- PVLA $46.29
- LNKB $9.00
- AVG Volume (30 Days)
- PVLA 129.2K
- LNKB 72.0K
- Earning Date
- PVLA 08-15-2025
- LNKB 07-28-2025
- Dividend Yield
- PVLA N/A
- LNKB 4.00%
- EPS Growth
- PVLA N/A
- LNKB N/A
- EPS
- PVLA N/A
- LNKB 0.97
- Revenue
- PVLA N/A
- LNKB $120,786,000.00
- Revenue This Year
- PVLA N/A
- LNKB $21.23
- Revenue Next Year
- PVLA N/A
- LNKB N/A
- P/E Ratio
- PVLA N/A
- LNKB $7.75
- Revenue Growth
- PVLA N/A
- LNKB 135.60
- 52 Week Low
- PVLA $11.17
- LNKB $6.00
- 52 Week High
- PVLA $29.27
- LNKB $7.98
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- LNKB 58.41
- Support Level
- PVLA N/A
- LNKB $6.67
- Resistance Level
- PVLA N/A
- LNKB $7.78
- Average True Range (ATR)
- PVLA 0.00
- LNKB 0.27
- MACD
- PVLA 0.00
- LNKB 0.04
- Stochastic Oscillator
- PVLA 0.00
- LNKB 77.24
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.